Accelerated Access Collaborative News Today

Despite laboratories’ longstanding reliance upon microbial culture for infectious disease identification, the pressures of the pandemic have incre...

The government’s policy to fast track “innovative” drugs into the NHS to showcase the UK as a great place for industry has been described as “a pretty spectacular failure,” because of the way a test case using the cholesterol lowering drug inclisiran was received. The rapid introduction of inclisiran into the UK was part of the government’s drive to help the country regain its “status as a science superpower” after Brexit,1 which would bypass some of the usual routes to getting a...

The Pharmaceutical Journal from the Royal Pharmaceutical Society

The Pharmaceutical Journal from the Royal Pharmaceutical Society

/PRNewswire/ -- The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Service Provider, By Company...

/PRNewswire/ -- Concert AIs TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum, a...

Sleep disturbance following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness. Due to the association with multiple symptoms, targeting sleep disturbance might be beneficial in treating the post-COVID-19 condition.

/PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, University of Nottingham and a consortium of NHS Trusts, announced...

Nine of the most promising artificial intelligence healthcare technologies to receive nearly £16 million in government funding to accelerate research

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!